Human papillomavirus (HPV)-related screening technologies and HPV vaccination offer
enormous potential for cancer prevention, notably prevention of cervical cancer. The …

Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …

Abstract Problem/Condition: Malaria in humans is caused by intraerythrocytic protozoa of the
genus Plasmodium. These parasites are transmitted by the bite of an infective female …

Young age at first sexual intercourse (AFI) is an important risk factor for cervical cancer, but
no simple statistical model of its influence has been established. We investigated the …

Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …

Background The success of human papillomavirus (HPV) national immunization program
depends on effective strategies in optimizing the uptake of HPV vaccine. Given the …

Background HPV is related to a number of cancer types, causing a considerable burden in
both genders in Europe. Female vaccination programs can substantially reduce the …

Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Background: With promising efficacy results from randomized control trials of human
papillomavirus (HPV) vaccines and the availability of new screening paradigms …

Quadrivalent human papillomavirus (HPV)[types 6, 11, 16, 18] recombinant vaccine
(Gardasil®; Silgard®) is composed of virus-like particles formed by self-assembly of …